Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Arthritis and Rheumatism
|
December 1, 1986
Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus
M D Lockshin, T Qamar, P Redecha, et al.
Transactions of the American Clinical and Climatological Association
|
January 1, 1995
Lipoprotein(a): searching for a function
P C Harpel, M Poon, X Zhang, et al.
Biochemistry
|
April 2, 1998
Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells
J N Liu, W Kung, P C Harpel, et al.
Biochemistry
|
September 21, 1993
Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator
J N Liu, P C Harpel, R Pannell, et al.
Blood
|
May 1, 1994
Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes
S Shibata, P C Harpel, A Gharavi, et al.
Thrombosis and Haemostasis
|
July 1, 1995
Lipoprotein(a), plasmin modulation, and atherogenesis
P C Harpel, A Hermann, X Zhang, et al.
Clinical Genetics
|
March 31, 1998
Apolipoprotein(a) is a human vascular endothelial cell agonist: studies on the induction in endothelial cells of monocyte chemotactic factor activity
M Poon, X Zhang, K Dunsky, et al.
Blood
|
October 1, 1989
Inhibition of tissue plasminogen activator activity by aspirin in vivo and its relationship to levels of tissue plasminogen activator inhibitor antigen, plasminogen activator and their complexes
R I Levin, P C Harpel, J G Harpel, et al.
The Journal of Clinical Investigation
|
December 1, 1987
Binding of tissue plasminogen activator to cultured human endothelial cells
K A Hajjar, N M Hamel, P C Harpel, et al.
The Journal of Biological Chemistry
|
August 25, 1985
Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation
R L Silverstein, R L Nachman, L L Leung, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Arthritis and Rheumatism
|
December 1, 1986
Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus
M D Lockshin, T Qamar, P Redecha, et al.
Transactions of the American Clinical and Climatological Association
|
January 1, 1995
Lipoprotein(a): searching for a function
P C Harpel, M Poon, X Zhang, et al.
Biochemistry
|
April 2, 1998
Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells
J N Liu, W Kung, P C Harpel, et al.
Biochemistry
|
September 21, 1993
Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator
J N Liu, P C Harpel, R Pannell, et al.
Blood
|
May 1, 1994
Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes
S Shibata, P C Harpel, A Gharavi, et al.
Thrombosis and Haemostasis
|
July 1, 1995
Lipoprotein(a), plasmin modulation, and atherogenesis
P C Harpel, A Hermann, X Zhang, et al.
Clinical Genetics
|
March 31, 1998
Apolipoprotein(a) is a human vascular endothelial cell agonist: studies on the induction in endothelial cells of monocyte chemotactic factor activity
M Poon, X Zhang, K Dunsky, et al.
Blood
|
October 1, 1989
Inhibition of tissue plasminogen activator activity by aspirin in vivo and its relationship to levels of tissue plasminogen activator inhibitor antigen, plasminogen activator and their complexes
R I Levin, P C Harpel, J G Harpel, et al.
The Journal of Clinical Investigation
|
December 1, 1987
Binding of tissue plasminogen activator to cultured human endothelial cells
K A Hajjar, N M Hamel, P C Harpel, et al.
The Journal of Biological Chemistry
|
August 25, 1985
Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation
R L Silverstein, R L Nachman, L L Leung, et al.
Page
of 9